Latham & Watkins Advises on Veradigm’s US$100 Million Term Loan Facility
Veradigm (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, has announced it has entered into a credit agreement with Wilmington Savings Fund Society, FSB, as administrative agent and collateral agent and several banks and other financial institutions as lenders, including certain affiliates of Francisco Partners. The credit agreement provides for a US$100 million senior secured term loan credit facility, consisting of a US$75 million initial term loan funded on June 18, 2025, and a US$25 million delayed draw term loan facility available until December 18, 2026, each with a maturity date of June 18, 2030. Proceeds from the borrowings under the credit agreement will be used for repurchases, if required, of Veradigm’s 0.875% convertible senior notes due 2027, and otherwise for general corporate purposes.
Latham & Watkins advised Francisco Partners in the transaction with a finance team led by partners Elizabeth Oh and Haim Zaltzman and counsel Emily Leong Yu, with associates Hyunji Lee and Nilam Faqhir, with assistance from Dominick Gambino. Advice was also provided on tax matters by partner Katharine Moir, with associate Sam Yang; on ERISA matters by counsel Aryeh Zuber; on converts matters by partner Reza Mojtabaee-Zamani and counsel Christopher Yu, with associate Ryan Gold; and on regulatory matters by partner Steve Feldman, with associate Nathan Sandals.